Gerard Schick v. Boehringer Ingelheim (Canada) Ltd., Boehringer Ingelheim Pharmaceuticals Inc. and Pfizer Inc.
What is this action about?
This action is about the drug Mirapex which was usually prescribed to persons suffering from Parkinson’s disease. Mirapex is a dopamine agonist and studies released years ago suggested there may be a link between ingesting the drug and compulsive gambling and other obsessive behaviours, including hypersexuality and compulsive or obsessive shopping.
Who is Eligible for this class?
Any Canadian who has taken Mirapex and has behaved compulsively or developed a compulsive gambling addiction or other such behavioural problems may be a class member. Please contact a lawyer at Thomson Rogers to determine if you fit into this class.
What is the claim?
The claim alleges (remembering that no allegations have yet been proven) that, amongst other things, the defendants Boehringer Ingelheim (Canada) Ltd., Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. breached their duty of care to individuals taking Mirapex, since they knew or ought to have known of the serious behavioural related complications associated with Mirapex and allegedly failed to adequately warn patients and physicians about the dangers of Mirapex. The actual claim, is available on our website.
When was this proceeding initiated by Thomson Rogers?
This claim was issued on May 5th, 2005.
Who is the representative plaintiff?
This action was commenced by the representative plaintiff Gerard Schick. Mr. Schick alleges that after taking Mirapex, he developed a compulsive gambling addiction.
How popular is Mirapex?
According to the 2006 annual report of Boehringer Ingelheim, Mirapex is the world’s best-selling dopamine agonist with a cumulative overall world wide exposure since 1997, of at least 2.2 million patient years. In other words thousands of people in Canada and elsewhere were prescribed this medication.
Is Mirapex Still on the Market?
Yes, Mirapex is still available. However, the consumer information portion attached to this product now warns those prescribed Mirapex that: “Patients and caregivers should be aware of the fact that abnormal behaviour such as pathological gambling, increased sexual desire, excessive sexual activity, compulsive shopping or binge eating have been reported.”
Is there ongoing Mirapex litigation in the United States?
There are many similar Mirapex cases ongoing in the United States. These actions are being conducted by way of the Multidistrict Litigation Process and these cases are being supervised by the United States District Court of Minnesota. In one case that went to trial a plaintiff was awarded $8.2 million (including punitive damages). If you are a U.S. citizen, with a potential claim, please contact an American personal injury lawyer to discuss your claim, as you are not covered or included in this Canadian class action.
How many people have registered with our firm?
More than 100 Canadians have registered for this class action with Thomson Rogers.
How do I register?
Please submit your information via our website at www.thomsonrogers.com or contact any of our class action lawyers for more information. If we have your contact information we will update you from time to time on the status of the case. Updates also appear on our website.
What is the Status of the Class Action?
This class action has not yet been certified. A motion for certification is still pending before the Courts.
What are the Costs of Participating in this Class Action?
Only the representative plaintiff is generally responsible for costs if this action is unsuccessful. There is no financial risk generally for class members.